Table II.
Characteristics | Prevalence
|
Prevalence ratio
|
|
---|---|---|---|
n† | % (95% CI) | (95% CI) | |
Age, y | |||
6–8 | 106 | 9.0 (7.3–11.0) | 1.00 |
9–11 | 153 | 11.8 (9.9–14.0) | 1.31 (1.03–1.66) |
12–16 | 228 | 8.4 (6.9–10.2) | 0.93 (0.71–1.21) |
17–19 | 224 | 15.0 (12.9–17.3) | 1.66 (1.33–2.08) |
Total (6–19) | 711 | 10.7 (9.6–11.9) | |
Sex and age, y | |||
6–8 | |||
Male | 46 | 7.3 (5.0–10.4) | 1.00 |
Female | 60 | 11.0 (8.2–14.6) | 1.51 (0.91–2.5) |
9–11 | |||
Male | 82 | 12.8 (10.1–16.1) | 1.00 |
Female | 71 | 10.8 (7.7–14.8) | 0.84 (0.54–1.31) |
12–16 | |||
Male | 133 | 9.3 (7.2–12.0) | 1.00 |
Female | 95 | 7.5 (5.5–10.1) | 0.80 (0.54–1.19) |
17–19 | |||
Male | 124 | 16.4 (13.0–20.5) | 1.00 |
Female | 100 | 13.4 (10.6–16.7) | 0.81 (0.57–1.15) |
Total (6–19 | |||
Male | 385 | 11.2 (9.7–12.9) | 1.00 |
Female | 326 | 10.1 (8.6–11.8) | 0.90 (0.73–1.11) |
Race/ethnicity and age, y | |||
6–8 | |||
Non-Hispanic white | 35 | 9.1 (6.7–12.4) | 1.00 |
Non-Hispanic black | 17 | 5.5 (3.1–9.4) | 0.60 (0.29–1.22) |
Mexican American | 34 | 8.8 (5.5–13.8) | 0.96 (0.58–1.59) |
9–11 | |||
Non-Hispanic white | 55 | 13.5 (10.5–17.1) | 1.00 |
Non-Hispanic black | 25 | 6.9 (4.8–9.8) | 0.51 (0.33–0.79) |
Mexican American | 45 | 9.8 (7.6–12.6) | 0.73 (0.52–1.04) |
12–16 | |||
Non-Hispanic white | 69 | 8.5 (6.2–11.5) | 1.00 |
Non-Hispanic black | 52 | 7.6 (6.1–9.5) | 0.90 (0.63–1.28) |
Mexican American | 78 | 9.0 (6.9–11.6) | 1.06 (0.70–1.60) |
17–19 | |||
Non-Hispanic white | 84 | 17.0 (13.8–20.8) | 1.00 |
Non-Hispanic black | 53 | 10.3 (7.9–13.2) | 0.60 (0.44–0.83) |
Mexican American | 62 | 12.9 (9.9–16.6) | 0.76 (0.55–1.05) |
Total (6–19) | |||
Non-Hispanic white | 243 | 11.5 (9.9–13.4) | 1.00 |
Non-Hispanic black | 147 | 7.7 (6.7–8.9) | 0.67 (0.54–0.82) |
Mexican American | 219 | 9.9 (8.6–11.5) | 0.86 (0.70–1.06) |
A high level of non-HDL-C was defined as serum non-HDL-C concentration ≥145 mg/dL.
Number of subjects with high level of non-HDL-C.